# Regional Lipolysis Insulin Regulation

> **NCT06392854** · EARLY_PHASE1 · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 48 (estimated)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Insulin

## Key facts

- **NCT ID:** NCT06392854
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-01
- **Primary completion:** 2028-06
- **Final completion:** 2028-06
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06392854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06392854, "Regional Lipolysis Insulin Regulation". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT06392854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*